Guillain–Barré syndrome

E196711

Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.

All labels observed (5)

How this entity was disambiguated

Statements (66)

Predicate Object
instanceOf acute inflammatory demyelinating polyradiculoneuropathy ⓘ
autoimmune disease ⓘ
neurological disorder ⓘ
peripheral neuropathy ⓘ
affectsSystem peripheral nervous system ⓘ
canAffect children ⓘ
hasCause autoimmune attack on peripheral nerves ⓘ
hasClinicalCourse acute ⓘ
monophasic ⓘ
hasComplication chronic neuropathic pain ⓘ
deep vein thrombosis ⓘ
paralysis ⓘ
pulmonary embolism ⓘ
respiratory failure ⓘ
hasDiagnosticFinding albuminocytologic dissociation in cerebrospinal fluid ⓘ
hasDiagnosticTest electromyography ⓘ
lumbar puncture ⓘ
nerve conduction studies ⓘ
hasIncidence about 1 to 2 cases per 100000 person-years ⓘ
hasMortalityRate approximately 3–7 percent ⓘ
hasOnsetPattern rapidly progressive ⓘ
hasPathophysiology immune-mediated axonal damage ⓘ
immune-mediated demyelination of peripheral nerves ⓘ
hasPrimarySymptom areflexia ⓘ
ascending muscle weakness ⓘ
hyporeflexia ⓘ
hasPrognosis most patients recover partially or completely ⓘ
hasSexDistribution slightly more common in males ⓘ
hasSubtype Miller Fisher syndrome ⓘ
acute inflammatory demyelinating polyradiculoneuropathy ⓘ
acute motor and sensory axonal neuropathy ⓘ
acute motor axonal neuropathy ⓘ
hasSymptom autonomic dysfunction ⓘ
blood pressure instability ⓘ
bulbar weakness ⓘ
cardiac arrhythmia ⓘ
facial weakness ⓘ
gait disturbance ⓘ
numbness in extremities ⓘ
paresthesia ⓘ
respiratory muscle weakness ⓘ
hasSynonym GBS ⓘ
acute inflammatory demyelinating polyneuropathy ⓘ
hasTreatment intravenous immunoglobulin ⓘ
mechanical ventilation ⓘ
physical rehabilitation ⓘ
plasma exchange ⓘ
supportive care ⓘ
thromboprophylaxis ⓘ
hasTypicalAgeGroup adults ⓘ
hasTypicalTrigger Campylobacter jejuni infection ⓘ
Epstein–Barr virus infection ⓘ
Mycoplasma pneumoniae infection ⓘ
Zika virus infection ⓘ
cytomegalovirus infection ⓘ
gastrointestinal infection ⓘ
infection ⓘ
influenza infection ⓘ
respiratory tract infection ⓘ
surgery ⓘ
vaccination ⓘ
isClassifiedUnder immune-mediated neuropathies ⓘ
rare diseases ⓘ
wasFirstDescribedBy Georges Guillain ⓘ
Jean Alexandre Barré ⓘ
wasFirstDescribedInYear 1916 ⓘ

How these facts were elicited

Referenced by (16)

Full triples — surface form annotated when it differs from this entity's canonical label.

Campylobacter → complication → Guillain–Barré syndrome ⓘ
Janssen COVID-19 Vaccine → rareAdverseEvents → Guillain–Barré syndrome ⓘ
2015–2016 Zika virus outbreak → associatedWith → Guillain–Barré syndrome ⓘ
Guillain–Barré syndrome → hasSubtype → acute inflammatory demyelinating polyradiculoneuropathy ⓘ
linked to: Guillain–Barré syndrome
Guillain–Barré syndrome → hasSubtype → acute motor axonal neuropathy ⓘ
linked to: Guillain–Barré syndrome
Guillain–Barré syndrome → hasSubtype → acute motor and sensory axonal neuropathy ⓘ
linked to: Guillain–Barré syndrome
Guillain–Barré syndrome → hasSubtype → Miller Fisher syndrome ⓘ
linked to: Guillain–Barré syndrome
Ad26.COV2.S → adverseEventOfSpecialInterest → Guillain–Barré syndrome ⓘ
Zika virus → associatedCondition → Guillain–Barré syndrome ⓘ
Óscar Tabárez → medicalCondition → Guillain–Barré syndrome ⓘ
Jean Alexandre Barré → coDiscovererOf → Guillain–Barré syndrome ⓘ
Jean Alexandre Barré → eponymOf → Guillain–Barré syndrome ⓘ
Epstein–Barr virus infection → associatedWithDisease → Guillain–Barré syndrome ⓘ
Georges Guillain → co-discovered → Guillain–Barré syndrome ⓘ
Jcovden → hasSeriousAdverseEffects → Guillain–Barré syndrome ⓘ
Jcovden → regulatoryLabelIncludesWarningFor → Guillain–Barré syndrome ⓘ